New Results
Rapid and parallel adaptive mutations in spike S1 drive clade success in SARS-CoV-2
View ORCID ProfileKathryn E. Kistler, View ORCID ProfileJohn Huddleston, View ORCID ProfileTrevor Bedford
doi: https://doi.org/10.1101/2021.09.11.459844
Kathryn E. Kistler
1Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, United States
2Molecular and Cellular Biology Program, University of Washington, Seattle, United States
John Huddleston
1Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, United States
Trevor Bedford
1Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, United States
Article usage
Posted September 12, 2021.
Rapid and parallel adaptive mutations in spike S1 drive clade success in SARS-CoV-2
Kathryn E. Kistler, John Huddleston, Trevor Bedford
bioRxiv 2021.09.11.459844; doi: https://doi.org/10.1101/2021.09.11.459844
Subject Area
Subject Areas
- Biochemistry (12785)
- Bioengineering (9672)
- Bioinformatics (31251)
- Biophysics (16091)
- Cancer Biology (13177)
- Cell Biology (18846)
- Clinical Trials (138)
- Developmental Biology (10202)
- Ecology (15185)
- Epidemiology (2067)
- Evolutionary Biology (19394)
- Genetics (12880)
- Genomics (17772)
- Immunology (12904)
- Microbiology (30203)
- Molecular Biology (12607)
- Neuroscience (65885)
- Paleontology (486)
- Pathology (2041)
- Pharmacology and Toxicology (3518)
- Physiology (5446)
- Plant Biology (11284)
- Synthetic Biology (3124)
- Systems Biology (7764)
- Zoology (1756)